@abpi.bsky.social
Medicines and vaccines are transforming our lives like never before. We represent the companies that make them possible. 📨 PressOffice@abpi.org.uk
Thinking about a career in the pharmaceutical industry?
It's #NationalApprenticeshipWeek & we are sharing the different routes into the industry, including apprenticeships, & the opportunities they open up.
Take a look: www.abpi.org.uk/careers/job-...
www.youtube.com/watch?v=fxXR...
#NAW2026
Despite continued advances in cancer research, UK patients can access fewer cancer medicines through the NHS than patients in comparable European countries.
Find out more about improving access to cancer medicines:
www.abpi.org.uk/publications...
What drives company decisions on new medicine launches and UK investment?
The findings of ABPI's 2025 Medicines Impact and Investment Survey track how UK policy conditions influence companies' investment and prioritisation decisions for medicines launches.
www.abpi.org.uk/media/blogs/...
At the moment, NHS patients with blood cancer can only access half of the approved medicines for their condition.
Reviewing how these medicines are valued is a first step to giving UK patients the treatments that could save or prolong their lives.
Learn more: www.ourcommongoal.org.uk/blood-cancer/
New breast cancer treatments can extend patients’ lives, yet some remain unavailable in parts of the UK.
Rethinking the way such medicines are valued and approved is a crucial first step in increasing access to life-extending care for more UK patients.
Find out more: www.ourcommongoal.org.uk
It's time to emphasise the economics in health economics. Victoria Jordan discusses the health economics of the UK-US Economic Prosperity Deal and plans increase NICE's baseline threshold use, the first change since its introduction in the early 2000s. abpi.uksouth01.umbraco.io/media/blogs/...
05.01.2026 09:58 — 👍 1 🔁 0 💬 0 📌 0Alzheimer’s devastates the lives of patients and their families, costing billions in care.
New treatments that can slow the disease’s progression in its early stages have recently been licensed in the UK - yet NHS patients are still being denied access.
Find out more: www.ourcommongoal.org.uk
#ABSWawards
As we prepare for the ABSW Awards 2026, we want to thank the partners whose continued support helps us celebrate excellence in science journalism...
@abpi.bsky.social
Dr Katharine Giles Fund
@royalsociety.org
AlphaGalileo
Want to be an ABSW Awards partner?
Find how👉 zurl.co/gPGgo
Publication of 'A Common Understanding 2025' marked an important milestone for collaborative working in Scotland earlier this year.
It shows how partnership across industry, academia & the NHS can improve patient care & drive innovation.
www.gov.scot/publications...
We’re proud to share our guidance on creating successful NHS-industry partnerships in Northern Ireland’s health & social care system.
Developed with @niconfederation.bsky.social, it’s designed to accelerate innovation and improve patient outcomes. www.abpi.org.uk/publications...
Earlier this year we launched joint guidance with @welshnhsconfed.bsky.social to help the NHS and industry work together more confidently, transparently & effectively.
📘 Download here to create successful partnerships for your organisation www.nhsconfed.org/publications...
#PartnershipWorking
NHS–industry partnership guidance is now in place across all 4 UK nations.
Developed with @nhsconfed.org, @welshnhsconfed.bsky.social, @niconfederation.bsky.social, and the Scottish Government, these frameworks support better outcomes for patients ⬇️
Find out more at www.abpi.org.uk/partnerships/
The payment rates for older branded medicines remain unchanged in 2026, with companies continuing to pay between 10% and 35% on their sales of each older medicine to the NHS, depending on the levels of price discount already offered to the NHS.
10.12.2025 09:39 — 👍 0 🔁 0 💬 0 📌 0
The VPAG payment rate for newer medicines will be 14.5% in 2026. With the addition of the 1% investment programme, the total rebate for newer medicines in 2026 will be 15.5% of revenues.
www.abpi.org.uk/media/news/2...
There’s been a drop in ppl participating in interventional industry clinical trials 📉
There are many potential reasons for this - lots of action underway to fix it 🔧
We're proposing further measures in our latest report.
abpi.org.uk/publications... @nihr.bsky.social
Did you know the 150-day target for setting up industry clinical trials has 3 parts? ⏱️🧪
We’re on track with some — but others need work.
Read our latest report: www.abpi.org.uk/publications... @nihr.bsky.social
🚨 Today's US–UK trade agreement "...is an important step towards ensuring patients can access the innovative medicines needed to improve wider NHS health outcomes.”
Read the full response from our Chief Executive
@torbett.bsky.social
abpi.org.uk/media/news/2...
Acid Sphingomyelinase Deficiency (ASMD) is a rare disease that shortens the lives of children & adults.
Treatments can halt symptoms & reverse disease progression, but many UK patients cannot access these medicines, even though they are available in over 50 countries.
www.ourcommongoal.org.uk
Sepsis is the body's reaction to a serious infection and is responsible thousands of deaths a year.
Antibiotics are essential for treating #sepsis but rising resistance means we must find new ones.
Learn more: www.togetherforantibiotics.org.uk
#TogetherForAntibiotics #WAAW #WAAW2025
Treating pneumonia without antibiotics is like a hot-air balloon without gas.
This week is World Antimicrobial Awareness Week and we’re highlighting how #AntimicrobialResistance remains a threat to modern medicine as we know it.
www.togetherforantibiotics.org.uk
#TogetherForAntibiotics #WAAW2025
NHS patients with blood cancer can only access half the approved medicines for their condition despite many of these treatments being available in other countries
The question: will the UK continue to leave blood cancer patients behind or give them access to new treatments? www.ourcommongoal.org.uk
Scotland's Life Sciences Strategy is out today, setting out a vision of how to boost the sector to benefit Scottish patients and the economy. @scottishgovernment.bsky.social
Read our response: www.abpi.org.uk/media/news/2...
Treatments for kidney disease are under threat from antibiotic resistance.
Without antibiotics, procedures like dialysis become far riskier.
Find out more: www.togetherforantibiotics.org.uk
#TogetherForAntibiotics #WAAW #WAAW2025 #AMR
3 people at the Senedd standing in front of a stall for promoting Working in partnerships guidance
ABPI Wales Head of External Affairs Joe Castle was joined by the Welsh First Minister @ the Senedd to discuss joint @welshnhsconfed.bsky.social guidance covering how industry & the NHS can work together to improve patient outcomes & support innovation across Wales.
www.nhsconfed.org/publications...
What if our treatments no longer worked?
Antibiotics are one of the most powerful tools in healthcare.
But resistance to them is rising.
Learn more: togetherforantibiotics.org.uk
#WAAW #WAAW2025 #AMR
New breast cancer treatments can extend patients’ lives, yet some remain unavailable in parts of the UK, even though people in the US and many European countries can access them.
Will the UK invest in cutting-edge therapies, or deny them to patients?
www.ourcommongoal.org.uk/breast-cancer/
ENG: www.nhsconfed.org/news/new-gui...
CYM: www.nhsconfed.org/news/canllaw...
Welsh NHS Confederation in partnership with abpi Working together: Guidance to support transformative pharmaceutical industry partnerships with the NHS in Wales November 2025
Conffederasiwn GIG Cymru mewn partneriaeth gydag abpi Gweithio gyda'n gilydd: Canllawiau i gefnogi partneriaethau trawsnewidiol y diwydiant fferyllol gyda'r GIG yng Nghymru Tachwedd 2025
📣 New guidance launch 📣
Ahead of #WelshConfed25, we have renewed our partnership with @abpi.bsky.social to launch a joint guidance that offers practical tools to help NHS and pharmaceutical organisations develop, implement and evaluate partnerships to improve patient outcomes.
Links 👇
Allan heddiw: Ein canllaw newydd ar y cyd â @welshnhsconfed.bsky.social i helpu i greu partneriaethau mwy effeithiol, tryloyw a thrawsnewidiol rhwng y GIG a'r diwydiant fferyllol ledled Cymru.
Canllaw ar gael nawr cyn #WelshConfed25
www.nhsconfed.org/publications...
Out today: Our new joint guidance with @welshnhsconfed.bsky.social to help create more effective, transparent and transformative partnerships between the NHS and the pharmaceutical industry across Wales.
Guidance available now ahead of #WelshConfed25
www.nhsconfed.org/publications...
